Gilenya is a new medication approved for treatment in patients at least ten years of age suffering from relapsing forms of multiple sclerosis (MS), including relapsing-remitting MS (RRMS), and active secondary progressive MS (SPMS) which is an advanced stage of MS coming after RRMS for many people. It may also be used in chronic inflammatory demyelinating polyneuropathy (CIDP), a form of Guillain-Barré syndrome.
Hepazec Film-coated Tablet 550 Mg is a very important medicine designed to relieve specific gastrointestinal and hepatic problems. In this guide, we go into finer...
Humira (adalimumab) is an injectable anti-tumor necrosis factor (anti-TNF) medication prescribed for treating conditions such as various forms of arthritis; ankylosing spondylitis; Crohn’s disease; ulcerative colitis; plaque psoriasis; uveitis.
Ibrutinib is a medicine that targets proteins in cancer cells and stops the cancer cells from growing. It treats certain types of cancer. Some of the cancers treated are mantle cell lymphoma, chronic lymphocytic leukemia, small lymphocytic lymphoma, marginal zone lymphoma, Waldenstrom macroglobulinemia, and chronic graft-versus-host disease.
Inlyta has been approved for use as a treatment for advanced renal cell carcinoma (RCC) in adults, either on its own or in conjunction with other medications
